Preclinical Quantification of Trastuzumab in Rat Plasma
In quantifying therapeutic peptides and proteins in biological matrices, traditional ELISA-only based techniques can suffer from high variability, narrow dynamic range, problems with selectivity and typically cannot use internal standards.
Download this app note to learn how immunoaffinity-high resolution accurate mass assay:
- Has increased selectivity and sensitivity
- Displays excellent robustness, reproducibility and dynamic range
- Enables the confirmation of both in vitro and in vivo peptide modifications
